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w Laue Crystallography: It’s show time 
Gregory K Farber (1995). Cwrr. Biol. 5, 108X-IWO. 
To understand how an enzyme catalyzes a chenlical reaction, 
enzyrnologms would like to a have a series of structures reprc- 
centmg all the important points of the reaction. Such ‘1 molccu- 
lx movie would give one J new type of enzyme mechanism - 
the structural mechanisln. X-ray crystallography is the obvious 
tool to use to determine the structural mechanism of an 
ellzyme, but monochromatic data collection takes hours, far 
longer than the milliseconds enzymes typically take to catalyze 
<I reaction. In the time required to collect the data, the enzyme 
cycles through many catalytic events, and the structure one sees 
is that of the enzyme with an empty active site (the unbound 
enz)me has a lower free energy than any intermediate). Such 
problems can now be overcome in two ways. By altering sub- 
strate and product concentrations in the crystal lattice, one can 
comctinles cause one intermediate to have a lamer free elierg) 
than all the others. and thus obtain its structure. It is no\v also 
pos\iblc to obtain complete data sets on a millisecond time\cale 
by using the polychromatic Lauc niethod of data collection at a 
synchrotron X-ray source.Thece methods, combined with site- 
directed mutagcnrsis, have recently been used to produce ATI 
almost complete view of how isocitrate dehydrogenase works. 
I October IWS. Ilispatch, Clrrrmr Hiolqq) 
w l)NA-Mismatch Repair: The intricacies of eukaryotic 
spell-checking 
Thomas A Kunkel (lW5). Cuvr. Biol. 5, lOc)l-1001. 
The rare errors left behind by the cell’s replication machinery 
arc later corrected by the spell-checking machinery, which 
undertakes post-replication DNA-misnmch repair. Interest in 
this process in human cells was greatly stimulated two years ago 
by studies suggesting that inactivation of mismatch repair may be 
the initial event leading to certain types of cancers. A flurry of 
reports in the last fe\v months suggest that the mismatch-repair 
system is more cornplcx than was previously thought. and that 
its multiple gene products participate in a variety of fundamen- 
tally unportant L>NA transactions. It appears that cukaryotic 
mismatch-repair genes, much like their bacterial counterparts, 
safeguard the genome from promiscuous genetic exchange 
between I>NA strands with less than perfect homology. Other 
evidence suggests that the mismatch-repair system may partici- 
pate in control of the cell cycle at the G2 ‘checkpoint’ that pre- 
vents cell-cycle progression in response to treatment with the 
base amalog h-thioguaninc or other L1NA-damaging agents. 
1 October lW.5, Dispatch, Clrrrcrlr Bidoyy 
b Protein-Protein Interactions: Putting the pieces together 
Ben Bax and Harren Jhoti (19%). Cum Biol. 5, 1119-l 121. 
The effector region of the Ras signalling molecule is known to 
be involved in interactions with downstream effector molecules 
such as the serine/threonine protein kinase Raf and phos- 
phatidylinositol 3-kinasc (PI 3-kinase). The mechanism by 
which Ras activates Raf involves direct association between the 
two proteins, mediated by Raf’s amino-terminal Kas-binding 
domain (RBD).Thc recently determined crystal structure of the 
Raf RBL) bound to the Kas homolog RaplA provides a strut- 
tural basis for understanding the interaction between Ras and 
Kaf, and nay also provide a vie\v of ho\v members of the hi&l) 
conserved l-I-3-3 family of proteins might bind to md regulate 
Raf.The recently determined structure\ of the 7 Lund 1: lsofornl\ 
of 14-3-3 show d chaiiiiel or clanip in the diilier whose iiillcr 
surface is highly conserved aliiongst different isoforni\. suggest- 
ing a binding Gte for a conserved protein modulr.The fact that 
14-3-Z proteins cm iorm heterodimcrs suggt’m that such hct- 
erodimers might bring t\vo different Ggl&ng 111o1ccu1cs 
together, end suggest3 a possible niech~inistic coiiliectioli 
bet\veell the ~.a): l<as and 14-3-3 protein\ activate I\& lbf mq 
be turned on by d combination ofl<,ts and kinases huch as Src 01 
Lck, or by a 14-3-3 heterodimcr plu5 l’K<Z, a kinasc kno\vn to 
be activated by 14-i-3 protcills.Thc idea that a l-1-3-3 hctero- 
dimer brings together PKC and Raf. allo\\ing I’K<: to phocpho- 
rylate and activate Raf. is attractive but unproven, and the i/r IGIV~ 
functions of 14-3-3 proteins are not yet clear. 
I October 1005, 11ispatch. CJIfrrcf~r Hioky~ 
b Cell Cycle: The NIMA kinase joins forces with Cdc2 
AndreLv M Fry and Erich A N~gg (1 005). Clfrr. Biol. 5. 
1 112-l 125. 
The Cdc2 protein kinuse is ‘1 corncrstonc in our u~~derstmdmg 
ofnlitosis.This kinase, conlposcd of the ~34 Ci11 catalytic subunit 
and a B-type cyclin Iregulatory subunit. i\ the pl-ototype for .I 
family of cyclin-dependent kinascs (Cl)Ks) required f6r cell- 
cycle progression in all eukaryotes. Intrigunngly, in the tilamell- 
tous fungus .-i~~~c;~il/m rridrdorrs, ,I second protcill kinase. NIMA. 
is also required for mitotic progression. At first sight. NIMA 
appeared to lie on a path\va~ independent of <:dc2, but recent 
developments suggest that &c two path\\a);s are illterlinked, 
with NIMA possibly being J substrate of the (1~1~2 kmasc. As is 
the case with cyclin IJ, a mutant of NIMA that i\ resistant to 
destruction by proteolysis CJLISCS nlitotic arrest.Thr isolation of 
Nek (NIMA-related kinasc) cl1NAs from mammals and the 
charactcrizatlon of 1~~1rnm Nck2 suggest that Cdc3 and NIMA 
may also coordmately regulate mitosis in higher cukaryotcs. 
1 October 1 WJ. L>ispatch, C~rrrcrtt Biolqcp 
b Identification and partial characterization of a domain 
in CFTR that may bind cyclic nucleotides directly 
Stephen K Sulllv3n. Luis I3 Agcllon and Rang Schick 
(1905). Cwi: Riol. 5, 1 1 Y-1 167. 
The cystic fibrosis transn~cn~branc regulator (CFTR) is a chlor- 
ide channel that is activated by cAMI’-dependent phosphoryl- 
ation. Its actimty is also stimulated by &MI’-dependent protein 
kinase and protein kinasc C. In a demonstration of a nev, 
pathway for the activation of CFTR, the authors compare the 
response to cAMP and to &Ml’ of CFTK expressed in ?G~prrs 
oocyte\. They show that inhibition of protein kmase activity 
does not diminish the response to &MI! and that a domain III 
the proximal portion of the third cytoplasmic loop resembles .I 
class of cyclic-nucleotide-binding domains (cNBI1s) related to 
that of the catabolitc-gene activator protein (CAP). Moreover. 
two point mutations in this domain, predicted to disrupt direct 
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contact with cGMP, alter the response to cGMP with no effect 
on the response to cAMl?The results support the idea that a site 
for direct cyclic-nucleotide activation has been identified on the 
CFTR,which may provide a useful target for pharmacological 
intervention in cystic fibrosis. 
1 October 1995, Research Paper, Curmt Biolqy 
b Role of the regulatory domain of the EGF-receptor 
cytoplasmic tail in selective binding of the clathrin- 
associated complex AP-2 
Werner Boll, Andreas Gallusser and Tomas Kirchhausen 
(1995). Cm Bid. 5, 1168-1178. 
Binding of the mitogenic epidermal growth factor (EGF) to the 
EGF receptor (EGF-R) leads to Eignaling events that stimulate 
cell growth. It also leads to the internalization of EGF-K in 
clathrin-coated pits and its subsequent lysosomal destruction, 
serving to down-regulate signaling. Clathrin-associated protein 
complexes (APs) link clathrin to the activated receptors, intcract- 
ing with the cytoplasmic tails of the receptors and promoting the 
assembly of the clathrin lattice.What it is not known is how the 
specificity of this interaction is controlled. Internalization is abol- 
ished in EGF-R mutants that lack a cytoplasmic kinase domain, 
but mutation of the auto-phosphorylation sites in the EGF-R 
does not prevent endocytosis.This paper examines the association 
between the EGF-R and the AP present on the cytoplasmic 
membrane, AP-2, observing a specific association both irl viva and 
if7 vitro which is not seen using the AP from the trans-Golgi 
network, AP-1. The EGF-R-All-2 association is dependent on 
the presence of the regulatory domain of the cytopla~mic tail of 
the receptor, but not on the kinase activity of the receptor. This 
suggests that the kinase activity of the receptor is required in 
endocytosis for a step other than the EGF-R-AI’-2 association, 
perhaps the phosphorylation of a third, unidentified protein. 
1 October 1995, Research Paper, Curmt Biolqyy 
b The chkl pathway is required to prevent mitosis 
following cell-cycle arrest at ‘start’ 
Anthony M  Carr, Mohammed Moudjou, Nicola J Bentley 
and Iain M  Hagan (1995). CUVV. Biol. 5, 1179-l 190. 
The cell cycle can be viewed as a ~34”“~ cycle, driven by the 
regular oscillations in the activity of this kinase. When the pro- 
gression of downstream events such as DNA replication are per- 
turbed, however, checkpoints can arrest the cell cycle until the 
error is corrected.The Chkl protein kinase has been implicated 
in the arrest of the cell cycle after DNA damage, although It is 
not required for arrest when DNA synthesis is inhibited. In this 
paper a new mitotic control pathway is defined in Srhizo- 
sarcharortqws yorrzbr (the Gl checkpoint); Chkl is found to be 
required to prevent cells arrested at ‘start’ (the point in Gl at 
which cells make the decision whether to enter the next cycle) 
from entering mitosis.Temperature-sensitive mutants in the Gl 
transcription factor encoded by the crlrl0 gene usually arrest at 
‘start’, but double mutants that are also defective for chk1 func- 
tion cannot arrest. They undergo an aberrant mitosis without, 
apparently, entering S-phase, as their cell cycle progression 
cannot be blocked by a DNA synthesis inhibitor.The Gl check- 
point may monitor the pre-replication complexes known to be 
present in Gl phase, thus preventing the cell from entering 
mitosis before it has begun DNA replication. 
1 October 1995, Research Paper, Ccrrrct~t Bidqy 
b Functional significance of cytochrome c oxidase structure 
Robert A  Scott (1995). Structure 3, 981-986. 
Cytochrome c oxidase is the third complex in the electron-transfer 
chain which generates the proton gradient necessary for oxidative 
phosphorylation. Phylogenetically, the three core subunits of 
cytochrome c oxidase appear to predate the evolution of oxygenic 
photosynthesis, presumably in a form that used an alternative to 
the present electron acceptor, molecular oxygcn.The structure of 
this complex has been sought to help explain its many activities: 
electron transport, oxygen activation and proton pumping. The 
author reviews the first two structures of cytochromr L oxidase, 
obtained from Pmmnrs hitrjfirnr~s and cow.Thc ctructurcs agree 
with each other and, in many regpcctc, u ith previous structure 
prediction\ made on the basis of hydropathy plots, mutagencsls 
and other structural probes.Thc number and length of transmrn- 
brane domains, the location of active sites coordinating the 
cytochromes and metal ligands, and two metal cofactor sites (for 
Zn’+ and Mg’+) were all cuccessfiilly predicted. In addition. the I? 
&rrifr@‘zrrs structure identifey a number of residues which may aid 
in proton transfer by a series of minor, redox-linked conforma- 
tional changes. Both structures reveal candidate residues Lvhich 
may function in electron transport by bridging the gaps between 
reaction centers. Confirmation of these proposed functions should 
be possible using standard techniques such as ir/ vitro mutagenetic. 
15 October 1095, MinirevIew Strrrrtl,rc 
b Evolutionary conservation in the hepatitis B  virus 
core structure: comparison of human and duck cores 
John M  Kcnney, Carl-Henrik von Bonsdorff, Michael Nacsal 
and Stephen D Fuller (1995). Strrrc-tlrrc 3, 1009-1019. 
Hepatitis B  virus (HBV) and the related hcp”dIlaviruscs have 
two layers surrounding their DNA genome: an outer men- 
branc composed of cellular lipids and viral envelope proteins, 
and an internal nuclcocapsid (or core) assembled from dimers 
of a single core protein.The exterior of the core interacts with 
the cnvrlope proteins in vu-al assembly. and its interior provide? 
a suitable environment for reverse transcription of the RNA 
pre-genomc. Previously, cryoelcctron microscopy was used to 
determine the three-dimensional structure of HBV core parti- 
cles. Here, the structure? of various core particles formed from 
full length and truncated core proteins from HBV and the 
related duck virus, DHBV, arc presented. I)eFpite substantial 
variation in the length and sequence of the duck and human 
core proteins, the particle5 appear largely similar, with a charac- 
teristic icosahedral organization. The core particles formed by 
proteinr expressed in E.dwric-hia r-oli clithfully reproduce the 
native core structure even in the absence of the viral genomc, 
confirming that proper astembly of the core is independent of 
gcnome packaging. The apparent sites of interaction between 
the core proteins and the gcnome are conserved between the 
duck and human viruses, but the projecting domamr on the 
exterior of the core, which appear to be responsible for intcr- 
actions between the core and envelope, vary. 
15 October 1995, Research article, Strrrrtrrrc 
b 2 A  crystal structure of an extracellular fragment of 
human CD40 ligand 
Michael Karpusas,Yen-Ming Hw, Jla-huai Wang, JeffThomson, 
Seth Ledcrman, Leonard Chess and 11avid Thomas (1995). 
Strfrftrwc 3, 1031-1039. 
The CD40 ligand (CD4OL) is a member of the tumor necrosis 
factor (TNF) family of proteins and is transiently expressed on 
the surface of activatedT cells.The binding of CD4OL to CD10. 
which is expressed on the surface of B  cells, provides an impor- 
tant pathway of cellular activation that is involved in essential 
immune system fLmction5 such as antibody isotype switching 
and establishing immunological memory. Several mutations of 
CD4OL are known to cause a severe immunodeficiency, known 
as hyper-IgM syndrome (HIGMS), .h c aracterized by an inability 
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to produce imn~u~~oglobulins of the IgC, IgA and IgE Isotypes. 
I~lh~bitol-s of CIXOL signaling might have important therapeutic 
,1pplic.ltionc. The Ciuthors determined the crystal structure of .\ 
wluble cxtracellular frqnent of human CL)>IOL. Although the 
~nolccule forms .I trimrr sm~ilar to that found for other mcmbm 
of the TNF tlrmily and exhibits ;I similar overall fold, the struc- 
tuw shmvs conGderJble differences m several loops includmg 
thaw pl-cdictrd to be involved in CD30 binding.Thc structure 
susgcst\ thx mxt of the HIGMS mmtions affect the folding 
,rlld stability of the molecule rdthcr thm the Cl)10-binding site 
directly. It is possible th,lt single mutations in the CI)lO-binding 
\ltc JTe iiisuiticialt to divupt CI~IO~CI>IOL bmding, md xc 
thcrctim clinically undetrctdblc. 
15 Octobcl- 1995, I<CSC.II-ch Article. .Str’~r~-frfrr 
F The solution structure of the Mu Ner protein reveals 
a helix-turn-helix DNA recognition motif 
Tel-es~ E Stl-zcleckd, G Marius Clorc and Angela M 
(;roncnbor~~ (1995). StU!itlflT 3. 10X7-109.5. 
The Mu Ncr pmtein is .I 7-l-xnino-,lcid. basic, DNA-bindins 
protrIll found in ph‘ige Mu. It belongs to a class of proteins, 
the cm .md reprecwr proteins, that regulate the sx\ritch from the 
1) wgcnlc to the 1) tic stdtc of the phdgc life cycle. LXcpitc the 
tilllctioml similarity bet~~ccn Mu Ner md the cro proteins of 
other phdgs, the proteins 5h.u-c no significmt sequence idcn- 
titv. The author\ wlvcd the three-dimensional solution struc- 
tul-c of Mu Ner by tllrec-dimensiorl,II and four~dilnellsional 
hctcronucle~~r m,ignetic xsomncc spectrotcopy.The structure 
consists of tivc a-helicc\, two of \vhich comprise J helis-turn- 
hclis (HTH) motif that is likely to be in cont.ict with I>NA. 
The cro protcm~ from ph.ge A md 334 also possess ;I HTH 
I>NA recognition nlotif.Thus, fLulctionJ similarity is coupled 
to wuctur.il siniiLlrity. Ieliding support to thr notion that 
phc+~ Mu ,md A nq 11.n~c .I couunon ancestor. The Ncr 
pt-otvin from phage 13 I OX .~nd the Nip protein from E. i-cl/i xc 
likvl\ to h,ive very similx tertiary wuctures due to high amino 
.icid xxlue~~c~ idcntlt) \vith Mu Ncr. 
IS Octohel- 1 99.5. I<c\ca-ch Article, Stnrctrrrc, 
F Crystal structure of thioredoxin-2 from Anabaena 
Mat-kku Saxincn. Florence K Gleason and Hnnr Eklund 
(1 9%). S/r.fKtlrrc. 3, 101)7~1 1 ox. 
Thioredosin\ xc‘ ubiquitous reducing agents capable of regu- 
l.ltlllg the .ictivlty of other enzymes by reducing disulfidcs. 
Thiol-edosiii-2 (Try-?) is one of t\vo thioredoxins found in the 
cv,lliob,icteriuin. .4rr&cv1a. It is present dt low lcvcls, and is one 
of the iiiost divcrg:ent thioredosins, mith 12 of 38 otherwise 
COII\CI-vvd Ire\idues Jtcrcd. I>espite these diffcrcncos and thf 
ovcr,rll IOU, level of hon~ology. the structure ofTrrs-? is highI) 
\ilinl,lr to thv previously dctcrmined structures of the 
&/wirl~i~~ co/i and human enzymes. Nexly ~11 secondary ctruc- 
ture relationships are conserved, and the conformation md 
disulfidc geometry of the d&w-site disulfide ring is almost 
identical between the E. c-o/i md .-lrmhacvra eilzymcs in spltc of 
the differcnccs in main-chain hydrogen bonding within thig 
region.Thc tyrosinv replacing the conservrd aspCirt.lte near the 
active site occupies more space ‘It the backside of the dlsultidc 
ring. md the alter,itions in structure induced by thix chmgc 
tidy hove J significant rffc.ct on sutxtmtc \pecificit): The 
.~IJ&zc~I~~ structure \ho\vc J Inrgcl- hydrophobic region nca- the 
Clctlvc-sitc cysteinm which mny Jso .Iffwt cr~zyme~suhstrl~t~ 
interactiolis.Tllus it dppcxs that single amino acid subxitutions 
,Iround the protein interaction drcd account for the unusual 
enzymatic .lctivitirs md substrate specificity ofTrx-2. 
15 October 1905. l<csemh Artlclc. Stlrfitl/rc’ 
F Structure of &-bungarotoxin: potassium channel 
binding by Kunitz modules and targeted phospholipase 
action 
I’ctcr 1~) K\vong, Neil Q McDonald. Paul I3 Slgler md 
Wayne A Hendrickson (1095). Srwrrrrw 3, 1 109-I 1 10. 
P-bungarotoxin is a heterodimcric neurotoxin consisting of J 
phospholipdse subunit linked by n disultide bond to J member 
of the Kunitz (pancrc,itic trypsin type) protease inhlbltor 
superfxnily. The tomi ha no protrdsc mhibitol- c,lp.icity. 
howevrr, md the Kunitz subunit XI-vcs illstedd to target the 
toxin to prc-symptic nien~brcunes via its interaction with d cut>- 
cl.~ss of \oltJyc-scnsiti\r K+ chmnels. Once bound, the lipoly- 
tic action of the toxin pcrmeabilizes md thus depolarizes the 
membrmr. Hcrc the Cluthors solve the structure of the toxin dt 
1.45 A. The channel binding regmn of the Kunitz subunit 
(identified by sequence comparison dud solvent ~~cccssibility) is 
at the oppositr end of the subunit horn the loop typicull) 
involved in pl-otense binding. .und i~ivolves the only other 
exposed loop in thr subunit. Rccognitioli of the channel 1~) 
the toxin 311,iy mimic the binding of sonic JS yet poorly chClr,ic- 
terizcd endogrnous ncuropeptides. which ‘ire‘ proposed to 
interxt with the K’ chnnncls directly: The phoq~holipase sub 
ullit 1s highly specific: its lmv lcvcl ot non-specific mcmbrme 
binding inay be due to ‘1 pxtially occluded, \ve‘lkly hydropho- 
bic dctivc sitc.This low dffinitv of binding is ovc’rcomc by the 
K’ chdnnrl-Kunitz subunit illtrraction, hvhich iii turn Leeds to 
displaccmcnt of thr occluding active-site residue of the phos- 
phohpxe into the membra~le tvhere it act\ J\ an Jllchor. The 
high specificity of the toxin. and the srpxatlon of the cClt;llytic 
md loc.llizCltion functions in tmv distinct subunits, mClkcs 
pmbungxotoxin <in ,ittrdctive cmdidnte for nmditicatmn to 
xhicvc the therapeutic datruction of infected cell\ ,ind 
enveloped vimice. 
IS October 1095. I<csearch Article. Sm~tl~r~ 
